Clinical and Experimental Vaccine Research

  • 제13권4호
  • /
  • Pages.359-369
  • /
  • 2024
  • /
  • 2287-3651(pISSN)
  • /
  • 2287-366X(eISSN)
대한백신학회 (The Korean Vaccine Society)
권호 표지
DOI QR코드

DOI QR Code

Completing the pieces of a puzzle: in-depth probing of Toxoplasma gondii rhoptry protein 4 as a promising target for vaccination using an in-silico approach

  • Masoud Foroutan (Department of Basic Medical Sciences, Faculty of Medicine, Abadan University of Medical Sciences) ;
  • Mohammad Mehdi Shadravan (Student Research Committee, Abadan University of Medical Sciences)
  • 투고 : 2024.07.14
  • 심사 : 2024.07.25
  • 발행 : 2024.10.31
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The present study aimed to evaluate the key characteristics of Toxoplasma gondii rhoptry protein 4 (TgROP4), including physicochemical parameters, structural features, immunogenic epitopes, and virtual immune simulation, using several bioinformatics-based servers and tools. Based on allergenicity and antigenicity outputs, the TgROP4 protein seemed to have an immunogenic and non-allergenic nature. The quality of the three-dimensional (3D) structure improved after refinement, according to the outcomes of the Ramachandran plot and the ProSA-web servers. ABCpred and SVMTriP web tools were used to predict linear B lymphocyte epitopes and found several promising epitopes. Acceptable antigenicity, hydrophilicity, beta-turn, Bepipred linear epitope 2.0, flexibility, and surface accessibility scores were obtained through the Immune Epitope Database (IEDB). Also, seven discontinuous B-cell epitopes ranging from scores 0.966 to 0.848 were found in the 3D model of TgROP4 via the ElliPro. The IEDB findings showed T-cell epitopes on TgROP4 protein are capable to strongly bind to the major histocompatibility complex classes. In silico immune simulation was performed using C-ImmSim server and showed three injections of TgROP4 protein at 4-week intervals is capable to elicit adequate humoral and cell-mediated immune responses.

키워드

과제정보

This work was supported by the Abadan University of Medical Sciences, Abadan, Iran (grant/award no., 1603).

참고문헌

  1. Robert-Gangneux F, Darde ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 2012;25:264-96. 
  2. Rostami A, Riahi SM, Gamble HR, et al. Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysis. Clin Microbiol Infect 2020;26:673-83. 
  3. Dubey JP. The history of Toxoplasma gondii: the first 100 years. J Eukaryot Microbiol 2008;55:467-75. 
  4. Antczak M, Dzitko K, Dlugonska H. Human toxoplasmosis: searching for novel chemotherapeutics. Biomed Pharmacother 2016;82:677-84. 
  5. Wang JL, Zhang NZ, Li TT, He JJ, Elsheikha HM, Zhu XQ. Advances in the development of anti-Toxoplasma gondii vaccines: challenges, opportunities, and perspectives. Trends Parasitol 2019;35:239-53. 
  6. Foroutan M, Ghaffarifar F, Sharifi Z, Dalimi A, Jorjani O. Rhoptry antigens as Toxoplasma gondii vaccine target. Clin Exp Vaccine Res 2019;8:4-26. 
  7. Dlugonska H. Toxoplasma rhoptries: unique secretory organelles and source of promising vaccine proteins for immunoprevention of toxoplasmosis. J Biomed Biotechnol 2008;2008:632424. 
  8. Carey KL, Jongco AM, Kim K, Ward GE. The Toxoplasma gondii rhoptry protein ROP4 is secreted into the parasitophorous vacuole and becomes phosphorylated in infected cells. Eukaryot Cell 2004;3:1320-30. 
  9. El Hajj H, Demey E, Poncet J, et al. The ROP2 family of Toxoplasma gondii rhoptry proteins: proteomic and genomic characterization and molecular modeling. Proteomics 2006;6:5773-84. 
  10. Dziadek B, Dziadek J, Dlugonska H. Identification of Toxoplasma gondii proteins binding human lactoferrin: a new aspect of rhoptry proteins function. Exp Parasitol 2007;115:277-82. 
  11. Wang Y, Wang G, Cai J, Yin H. Review on the identification and role of Toxoplasma gondii antigenic epitopes. Parasitol Res 2016;115:459-68. 
  12. Foroutan M, Ghaffarifar F, Sharifi Z, Dalimi A, Pirestani M. Bioinformatics analysis of ROP8 protein to improve vaccine design against Toxoplasma gondii. Infect Genet Evol 2018;62:193-204. 
  13. Kazi A, Chuah C, Majeed AB, Leow CH, Lim BH, Leow CY. Current progress of immunoinformatics approach harnessed for cellular- and antibody-dependent vaccine design. Pathog Glob Health 2018;112:123-31. 
  14. Foroutan M, Ghaffarifar F, Sharifi Z, Dalimi A. Vaccination with a novel multi-epitope ROP8 DNA vaccine against acute Toxoplasma gondii infection induces strong B and T cell responses in mice. Comp Immunol Microbiol Infect Dis 2020;69:101413. 
  15. El-Kady IM. T-cell immunity in human chronic toxoplasmosis. J Egypt Soc Parasitol 2011;41:17-28. 
  16. Foroutan M, Ghaffari AD, Soltani S, Majidiani H, Taghipour A, Sabaghan M. Bioinformatics analysis of calcium-dependent protein kinase 4 (CDPK4) as Toxoplasma gondii vaccine target. BMC Res Notes 2021;14:50. 
  17. Rapin N, Lund O, Bernaschi M, Castiglione F. Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system. PLoS One 2010;5:e9862.